AAAAAA

   
Results: 1-3 |
Results: 3
CANCER RISK AFTER ADJUVANT CHEMOTHERAPY OR CHEMOHORMONAL THERAPY OF BREAST-CANCER
Authors: KUMPULAINEN EJ HIRVIKOSKI PP PUKKALA E JOHANSSON RT
Citation: Ej. Kumpulainen et al., CANCER RISK AFTER ADJUVANT CHEMOTHERAPY OR CHEMOHORMONAL THERAPY OF BREAST-CANCER, Anti-cancer drugs, 9(2), 1998, pp. 131-134
CNF COMBINATION AS ADJUVANT TREATMENT IN BREAST-CANCER PATIENTS IS WELL TOLERATED
Authors: HIRVIKOSKI PP KUMPULAINEN EJ JOHANSSON RT
Citation: Pp. Hirvikoski et al., CNF COMBINATION AS ADJUVANT TREATMENT IN BREAST-CANCER PATIENTS IS WELL TOLERATED, Anti-cancer drugs, 8(4), 1997, pp. 376-378
HEPATIC TOXICITY CAUSED BY ADJUVANT CMF CNF IN BREAST-CANCER PATIENTSAND REVERSAL BY TAMOXIFEN/
Authors: HIRVIKOSKI PP KUMPULAINEN EJ JOHANSSON RT
Citation: Pp. Hirvikoski et al., HEPATIC TOXICITY CAUSED BY ADJUVANT CMF CNF IN BREAST-CANCER PATIENTSAND REVERSAL BY TAMOXIFEN/, Breast cancer research and treatment, 44(3), 1997, pp. 269-274
Risultati: 1-3 |